Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300036
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $21,940
Award facts
- Contract value 100% obligated
- $21,939.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Valencia, CA 91355, USA
Award details come from SAM.gov/FPDS.
About this award
Qiagen, LLC received a $21,939.84 firm fixed-price Blanket Purchase Agreement (BPA) call for drugs and biologicals on January 11, 2016, with an ultimate completion date of April 30, 2016. The contract was awarded by a civilian federal agency without a set-aside designation, and performance is located in Valencia, California. As a child entity of Qiagen N.V., a multinational biotechnology company headquartered in the Netherlands, Qiagen, LLC specializes in molecular diagnostics, scientific equipment, and bioinformatics solutions. The company supplies reagents, consumables, and diagnostic testing kits to numerous federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, Department of Defense, and Federal Bureau of Investigation.
This BPA call represents a task order executed under a larger blanket purchase agreement vehicle, reflecting Qiagen's established relationship with the federal government for procurement of specialized molecular diagnostics products and services. The company holds multiple significant indefinite delivery vehicles across federal agencies, including a $6.5 million BPA with the Defense Health Agency for pharmaceutical products and a $2.56 million BPA with Veterans Integrated Service Network 22 for tuberculosis testing reagents. Given Qiagen's portfolio of tuberculosis diagnostics and other infectious disease testing capabilities, this award likely involved procurement of specialized reagents or consumables supporting government research, healthcare, or public health initiatives.
Quick answers
Who was awarded contract HHSN26300036?
HHSN26300036 was awarded to Qiagen, LLC by Office of the Director (National Institutes of Health) on January 11, 2016.
How much is contract HHSN26300036 worth?
The government has obligated $21,940 on HHSN26300036.
Is contract HHSN26300036 an order under another contract?
Yes. HHSN26300036 is a BPA call under HHSN263201500079B, a blanket purchase agreement.
Was contract HHSN26300036 competed?
The extent of competition for HHSN26300036 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award